rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Pediatrix Medical Group, Inc.

MD · NYSE

Health CareProviders & FacilitiesLeading

MD stood above a rising 150-day average in 48 of the last 52 weekly readings, including each of the last 21 weeks. It is 12.2% above that average now. Providers & Facilities: 45% of its 53 stocks in an uptrend (−6 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Leading
Weeks in an uptrend
21 in a row
Industry in uptrend
45% -6 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$2.7M
Officials’ trades on record
17

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 48 of 52 weeks.

17 Apr – 16 Oct
26%43%59%Apr 26Jun 26Jul 26Sep 26Oct 26

Providers & Facilities: About half its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1.6M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars. Not yet read: institutions.

Congress and officials

17 disclosed lines: House 15, Senate 0, executive 2; 6 people.

WhoDidAmountTraded
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$15k–$50k15 May 2026filed 1 Jul 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$15k–$50k4 Mar 2026filed 14 May 2026
Donna E. Shalala House: U.S. House ClerkFL27sold$50k–$100k15 Oct 2019filed 27 Apr 2020
Greg Gianforte House: U.S. House ClerkMT00sold$50k–$100k26 Oct 2018filed 29 Oct 2018
Greg Gianforte House: U.S. House ClerkMT00bought$100k–$250k29 Jan 2018filed 8 Feb 2018
Greg Gianforte House: U.S. House ClerkMT00sold$100k–$250k29 Dec 2017filed 4 Jan 2018
James B. Renacci House: U.S. House ClerkOH16sold$1k–$15k3 Aug 2017filed 22 Aug 2017
Lamar Smith House: U.S. House ClerkTX21sold$1k–$15k25 Apr 2017filed 7 May 2017
Lamar Smith House: U.S. House ClerkTX21sold$1k–$15k17 Mar 2017filed 10 Apr 2017
James B. Renacci House: U.S. House ClerkOH16bought$1k–$15k30 Jan 2017filed 7 Feb 2017
James B. Renacci House: U.S. House ClerkOH16sold$1k–$15k20 Dec 2016filed 5 Jan 2017
James B. Renacci House: U.S. House ClerkOH16bought$1k–$15k29 Jul 2016filed 3 Aug 2016

Insiders

Buy orders, 12 months0
Sale orders, 12 months4
Buyers · sellers0 · 4
WhoDidSharesTraded
Shirley A. WeisDirectorsold36,028at $23.7513 May 2026filed 14 May 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Still reading this part; it fills in a moment.

News

No headline names it lately.

Everyone who traded it

Laura A. Linynsky Company insiderDirector · last 10 Sep 20260 · 2
Sylvia Jean Young Company insiderDirector · last 14 Aug 20260 · 0
Guy P. Sansone Company insiderDirector · last 12 Aug 20260 · 0
John M. Starcher Jr. Company insiderDirector · last 12 Aug 20260 · 0
Kurt Douglas Newman Company insiderDirector · last 12 Aug 20260 · 0
Michael A. Rucker Company insiderDirector · last 12 Aug 20260 · 1
Shirley A. Weis Company insiderDirector · last 12 Aug 20260 · 3
Thomas McEachin Company insiderDirector · last 12 Aug 20260 · 0
David Haddock Company insiderEVP, GC & Corp Sec · last 22 Jun 20260 · 0
Mary Ann E. Moore Company insiderEVP, GC, Chief Admin Off & Sec · last 9 Jun 20260 · 2
Mark S. Ordan Company insiderChief Executive Officer · last 2 Jun 20260 · 5
Don Gregory Neeb Company insiderEVP, Chief Invest & Strategy · last 1 Jun 20260 · 0

Same industry

PACS PACS GroupLeading+18%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Operating profit marginFY 2025 · to 31 Dec 202510.9%
Return on capital employedFY 2025 · to 31 Dec 202511.7%
Cash conversionFY 2025 · to 31 Dec 2025164%
Share count trendFY 2025 · to 13 Feb 20260.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$375.2M

Analyst forecasts

No analyst forecasts yet.